1613396-30-7

Basic information

• Product Name: 4-amino-1-[1-[1-(4-fluorophenyl)-5-isopropylpyrazol-4-yl]-2-oxo-pyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonitrile
• Synonyms: 4-amino-1-[1-[1-(4-fluorophenyl)-5-isopropylpyrazol-4-yl]-2-oxo-pyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonitrile
• CAS NO: 1613396-30-7
• Molecular Weight: 445.459
• Mol File: 1613396-30-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-amino-1-[1-[1-(4-fluorophenyl)-5-isopropylpyrazol-4-yl]-2-oxo-pyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-amino-1-[1-[1-(4-fluorophenyl)-5-isopropylpyrazol-4-yl]-2-oxo-pyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonitrile(1613396-30-7)
• EPA Substance Registry System: 4-amino-1-[1-[1-(4-fluorophenyl)-5-isopropylpyrazol-4-yl]-2-oxo-pyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonitrile(1613396-30-7)

Safety Data

• Hazardous Substances Data: 1613396-30-7(Hazardous Substances Data)

Upstream product

• 1512322-11-0 1-(4-fluorophenyl)-5-isopropyl-1H-pyrazol-4-amine 
• 1613396-15-8 2-bromo-N-[1-(4-fluorophenyl)-5-isopropylpyrazol-4-yl]-4-hydroxybutanamide 
• 1613396-17-0 C₁₇H₂₁BrFN₃O₄S 
• 6826-96-6 4-amino-3-cyano-pyrazolo<3,4-d>pyrimidine 
• 1613396-19-2 3-bromo-1-[1-(4-fluorophenyl)-5-isopropylpyrazol-4-yl]pyrrolidin-2-one 

Downstream Products

• 1613396-33-0 3-[4-amino-3-(4,5-dihydro-1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-[1-(4-fluorophenyl)-5-isopropylpyrazol-4-yl]pyrrolidin-2-one 
• 1613395-24-6 3-[4-amino-3-(1H-imidazol-2-yl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-[1-(4-fluorophenyl)-5-isopropylpyrazol-4-yl]pyrrolidin-2-one trifluoroacetate 

Relevant articles and documents

DIAZOLE LACTAMS

Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are diazole lactam derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated disease, and as controls in assays for the identification of competitive CCR1 antagonists.